<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Asthma in children younger than 12 years: Initial evaluation and diagnosis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Asthma in children younger than 12 years: Initial evaluation and diagnosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Asthma in children younger than 12 years: Initial evaluation and diagnosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Gregory Sawicki, MD, MPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kenan Haver, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert A Wood, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Gregory Redding, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elizabeth TePas, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 25, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Asthma is a significant health problem worldwide, and it is one of the most common chronic diseases of childhood in many countries [<a href="#rid1">1,2</a>]. The prevalence in different countries ranges from 1 to 18 percent. In the United States, for example, over nine million children have been ever told they had asthma, and 5.5 million still have asthma [<a href="#rid3">3</a>]. Establishing a diagnosis of asthma involves a careful process of history taking, physical examination, and diagnostic studies. The differential diagnosis of wheezing and/or cough must be carefully considered, particularly in infants and very young children, for whom testing for reversible airflow obstruction is not easy to perform and not done routinely  (<a class="graphic graphic_table graphicRef67370" href="/z/d/graphic/67370.html" rel="external">table 1</a> and <a class="graphic graphic_table graphicRef62889" href="/z/d/graphic/62889.html" rel="external">table 2</a> and <a class="graphic graphic_table graphicRef113206" href="/z/d/graphic/113206.html" rel="external">table 3</a> and <a class="graphic graphic_algorithm graphicRef113691" href="/z/d/graphic/113691.html" rel="external">algorithm 1</a>).</p><p>The epidemiology, initial evaluation, and diagnosis of childhood asthma are reviewed here. The assessment of severity/control and monitoring and treatment of childhood asthma are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/90904.html" rel="external">"Asthma in children younger than 12 years: Overview of initiating therapy and monitoring control"</a> and  <a class="medical medical_review" href="/z/d/html/5744.html" rel="external">"Asthma in children younger than 12 years: Management of persistent asthma with controller therapies"</a> and  <a class="medical medical_review" href="/z/d/html/5743.html" rel="external">"Asthma in children younger than 12 years: Quick-relief (rescue) treatment for acute symptoms"</a>.)</p><p>The pathogenesis, genetics, risk factors, and natural history of asthma are also reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/522.html" rel="external">"Pathogenesis of asthma"</a> and  <a class="medical medical_review" href="/z/d/html/561.html" rel="external">"Genetics of asthma"</a> and  <a class="medical medical_review" href="/z/d/html/572.html" rel="external">"Risk factors for asthma"</a> and  <a class="medical medical_review" href="/z/d/html/13585.html" rel="external">"Wheezing phenotypes and prediction of asthma in young children"</a> and  <a class="medical medical_review" href="/z/d/html/567.html" rel="external">"Natural history of asthma"</a>.)</p><p class="headingAnchor" id="H2674983681"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>A wide global variation exists in the prevalence of asthma, with higher rates typically seen in higher-income countries [<a href="#rid4">4</a>]. Asthma is the most common chronic disease in childhood in resource-rich countries. A significant increase in the estimated prevalence of asthma was seen in resource-rich countries in the 1980s and 1990s, with slower rates of increase in the 2000s and a plateau thereafter [<a href="#rid5">5</a>]. Approximately 5.8 percent of US children had asthma in 2020, down from 7.5 percent in 2018 and 9.4 percent in 2010 [<a href="#rid6">6,7</a>]. However, asthma prevalence continues to increase in other countries such as China [<a href="#rid8">8</a>]. Possible causes that impact asthma prevalence are reviewed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/5548.html" rel="external">"Increasing prevalence of asthma and allergic rhinitis and the role of environmental factors"</a>.)</p><p>Disparities in prevalence remain, with higher prevalence seen in children with lower access to resources and those living in the Southern US and the highest prevalence still seen in Puerto Rican and non-Hispanic Black American children, particularly for those living in urban environments [<a href="#rid6">6,9,10</a>]. Before the onset of puberty, boys have a higher current prevalence of asthma than girls (9.2 versus 7.4 percent) [<a href="#rid3">3,11</a>]. This trend reverses in adolescence, the reasons for which remain unknown. Lifetime asthma prevalence for children was 12.7 percent in 2013 and 2016. The prevalence of asthma appears to have plateaued in other countries as well [<a href="#rid12">12-16</a>].</p><p>Asthma exacerbation rates among children with current asthma in the United States decreased from a rate of 62 percent among children &lt;18 years old in 2001 to 48 percent in 2014 but increased in 2016 to 54 percent [<a href="#rid3">3,10</a>].</p><p class="headingAnchor" id="H2"><span class="h1">HISTORY</span><span class="headingEndMark"> — </span>The history in a child with suspected asthma should focus on the presence of symptoms, typical symptom patterns, precipitating factors or conditions (ie, atopy), and known asthma risk factors  (<a class="graphic graphic_table graphicRef79182" href="/z/d/graphic/79182.html" rel="external">table 4</a>).</p><p>Additional history that should be obtained in a child with established asthma who presents for disease monitoring includes previous and current therapy (controller and quick-relief medication use), exposure to triggers, utilization of health care services (emergency department [ED], hospital, unscheduled clinic visits), school attendance and performance, and participation in physical activity. Review of an asthma questionnaire such as the Asthma Control Test may provide additional useful information. (See  <a class="medical medical_review" href="/z/d/html/90904.html" rel="external">"Asthma in children younger than 12 years: Overview of initiating therapy and monitoring control", section on 'Assessment of control'</a>.)</p><p>The evaluation of a child who presents with an acute asthma exacerbation is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5740.html" rel="external">"Acute asthma exacerbations in children younger than 12 years: Emergency department management"</a>.)</p><p class="headingAnchor" id="H3"><span class="h2">Symptoms</span><span class="headingEndMark"> — </span>Evaluating the presence of asthma symptoms is an important first step in establishing a proper diagnosis. Coughing and wheezing are the most common symptoms of childhood asthma. Breathlessness, chest tightness or pressure, and chest pain also are reported. Poor school performance and fatigue may indicate sleep deprivation from nocturnal symptoms.</p><p class="headingAnchor" id="H4"><span class="h3">Cough</span><span class="headingEndMark"> — </span>The presence of a nocturnal cough, a cough that recurs seasonally, a cough in response to specific exposures (eg, cold air, exercise, laughing, allergen exposure, or crying), or a cough that lasts more than three weeks, especially after an acute respiratory infection (see <a class="local">'Respiratory tract infections'</a> below), should raise the suspicion for asthma [<a href="#rid17">17</a>]. Although wheezing is considered the hallmark of childhood asthma, cough is frequently the sole presenting complaint [<a href="#rid18">18</a>]. The most common cause of chronic cough in children older than three years is asthma, even if it is not accompanied by wheezing. The cough is typically dry and hacking but may be productive; when the cough is productive, clear or whitish sputum may be expectorated (which often contains eosinophils). It is not unusual for chronic cough lasting more than three weeks to be labeled "bronchitis" and to be treated with medications such as cough suppressants, decongestants, or antibiotics. However, these types of cough may be manifestations of asthma and are likely to respond to asthma therapy. (See  <a class="medical medical_review" href="/z/d/html/6343.html" rel="external">"Approach to chronic cough in children"</a>.)</p><p class="headingAnchor" id="H5"><span class="h3">Wheeze</span><span class="headingEndMark"> — </span>Wheezing is a high-pitched, musical sound produced when air is forced through narrow airways. The wheezing of asthma tends to be polyphonic (varied in pitch), reflecting the heterogeneous distribution of affected airways. When airflow obstruction becomes severe, wheezing can be heard on both inspiration and expiration. In contrast to asthma, central airway obstruction may cause a harsh expiratory monophonic wheeze, as occurs with tracheomalacia. Upper airway obstruction (eg, vocal cord dysfunction) should be suspected if an inspiratory monophonic (of single pitch) wheeze (typically called stridor) is the only audible sound episodically. (See  <a class="medical medical_review" href="/z/d/html/6380.html" rel="external">"Assessment of stridor in children"</a>.)</p><p>A silent chest in the context of an asthma exacerbation implies airflow limitation of such severity that audible wheezes cannot be produced; this represents a medical emergency. (See  <a class="medical medical_review" href="/z/d/html/5740.html" rel="external">"Acute asthma exacerbations in children younger than 12 years: Emergency department management"</a>.)</p><p class="headingAnchor" id="H6"><span class="h3">Seasonal symptoms</span><span class="headingEndMark"> — </span>Symptoms that are worse in certain pollen seasons are characteristic of atopic asthma. Trees in temperate climates pollinate in early spring, grasses in summer, and weeds in the fall. Children who are sensitive to molds tend to wheeze or cough during rainy seasons or if they are exposed to flooding or indoor dampness. Other allergic symptoms, such as rhinitis, conjunctivitis, or eczema, may flare concurrently with the chest complaints. (See  <a class="medical medical_review" href="/z/d/html/7528.html" rel="external">"Chronic rhinosinusitis: Clinical manifestations, pathophysiology, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/5547.html" rel="external">"Allergic conjunctivitis: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/1729.html" rel="external">"Atopic dermatitis (eczema): Pathogenesis, clinical manifestations, and diagnosis"</a>.)</p><p class="headingAnchor" id="H7"><span class="h3">Symptom patterns</span><span class="headingEndMark"> — </span>Chronic asthma symptoms assume several typical patterns:</p><p class="bulletIndent1"><span class="glyph">●</span>Intermittent exacerbations superimposed upon an asymptomatic baseline</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Chronic symptoms punctuated by periods of worsening symptoms</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Morning "dipping" (an accentuation of the physiologic cycle of pulmonary function in normal individuals, characterized by worsening of symptoms and decreased peak flow in the early morning, with improvement as the day progresses)</p><p></p><p class="headingAnchor" id="H8"><span class="h2">Precipitating factors</span><span class="headingEndMark"> — </span>Wheezing or cough may occur at any time, but certain patterns and precipitating factors  (<a class="graphic graphic_table graphicRef80507" href="/z/d/graphic/80507.html" rel="external">table 5</a>) are typical. Depending upon the type and intensity of the provocative agent, most acute asthma exacerbations have a slow onset over several days. Uncommonly, severe attacks may occur suddenly and with minimal warning, resulting in life-threatening exacerbations [<a href="#rid19">19-23</a>]. (See  <a class="medical medical_review" href="/z/d/html/5740.html" rel="external">"Acute asthma exacerbations in children younger than 12 years: Emergency department management"</a> and  <a class="medical medical_review" href="/z/d/html/562.html" rel="external">"Trigger control to enhance asthma management"</a>.)</p><p class="headingAnchor" id="H9"><span class="h3">Respiratory tract infections</span><span class="headingEndMark"> — </span>Viral upper respiratory infections (URIs) are the most important triggering factor for patients with asthma of all ages, including infants and young children [<a href="#rid24">24</a>]. Clustering of asthma attacks between fall and spring suggests viral illness-induced phenomena [<a href="#rid25">25,26</a>]. Among children who are hospitalized for wheezing, respiratory syncytial virus, influenza virus, and rhinovirus are most common in those younger than three years (depending upon the season); rhinovirus is most common among older children [<a href="#rid25">25</a>]. (See  <a class="medical medical_review" href="/z/d/html/535.html" rel="external">"Role of viruses in wheezing and asthma: An overview"</a>.)</p><p>One study found that clusters of asthma hospitalizations in school-aged children in Canada occurred predictably after they returned to school following summer vacation and other breaks [<a href="#rid27">27</a>]. Specifically, there was a "September asthma epidemic" approximately 18 days after Labor Day (the first Monday of September), with a lesser increase in attacks two days later in preschool children and six days later in adults. Viral infections were the presumed cause, although a reduction in daily asthma medication use (eg, therapeutic holiday) during the summer months has also been implicated.</p><p>Chronic sinusitis (which is often bacterial) and respiratory infections due to <em>Mycoplasma pneumoniae</em> and <em>Chlamydia</em> <em>pneumoniae</em> may precipitate worsening of asthma [<a href="#rid28">28-32</a>]. (See  <a class="medical medical_review" href="/z/d/html/5957.html" rel="external">"Pneumonia caused by <i>Chlamydia pneumoniae</i> in children"</a> and  <a class="medical medical_review" href="/z/d/html/6070.html" rel="external">"<i>Mycoplasma pneumoniae</i> infection in children", section on 'Other respiratory manifestations'</a>.)</p><p class="headingAnchor" id="H10"><span class="h3">Exercise</span><span class="headingEndMark"> — </span>Exercise-induced bronchospasm (EIB) has a high positive predictive value for presence of asthma and may be the only manifestation of asthma in children [<a href="#rid33">33,34</a>]. It occurs in up to 90 percent of children with asthma [<a href="#rid35">35</a>].</p><p>Typical symptoms are shortness of breath, chest tightness, and cough. Exercise-triggered symptoms typically develop several minutes into prolonged exercise. Symptoms usually resolve with rest over 30 to 60 minutes. Lung function changes little or may even improve somewhat during most of the actual period of exercise. Lung function may begin to deteriorate towards the end of the exercise period and can fall quite markedly in some patients. The major fall in lung function normally occurs 5 to 10 minutes after stopping the exercise. Lung function then normally returns spontaneously to baseline over 30 to 45 minutes. A late-phase reaction occurs in a small proportion of patients with asthma [<a href="#rid36">36</a>], and some patients have both an immediate and a late-phase response to exercise [<a href="#rid37">37</a>]. (See  <a class="medical medical_review" href="/z/d/html/533.html" rel="external">"Exercise-induced bronchoconstriction"</a>.)</p><p>Certain types of exertion (eg, swimming) appear to be less provocative of asthma than others (eg, running, skating), probably because they produce less airway cooling and drying, which are thought to be provocative of EIB [<a href="#rid33">33</a>]. In a systematic review, patients with stable asthma who participated in swimming training had improved lung function and physical fitness, with no change in asthma symptoms or exacerbations [<a href="#rid38">38</a>]. However, there is an ongoing debate about potential lung damage caused by repeated respiratory exposure to chlorine byproducts in recreational swimmers [<a href="#rid39">39-42</a>]. We allow our patients to swim in pools and only advise against it if chlorine appears to be an irritant trigger in a particular patient.</p><p>Short bursts of activity tend to be better tolerated than prolonged exercise. Repeated short periods of exercise tend to result in diminishing EIB with each episode. Nonetheless, children with asthma do not need to be steered toward particular sports, since they can participate in sports at any level (including the Olympics) with proper treatment, and improved exercise conditioning leads to lower respiratory rates with the same level of activity.</p><p>If untreated, longstanding EIB may result in poor overall fitness, decreased exercise stamina, a preference for a sedentary lifestyle, and exercise avoidance due to the distress brought on by physical activity. EIB that is difficult to control often indicates inadequately controlled underlying asthma.</p><p class="headingAnchor" id="H11"><span class="h3">Weather</span><span class="headingEndMark"> — </span>Cold air; hot, humid air; changes in barometric pressure; rain; thunderstorms; or wind may be provocative factors for asthma in individual patients. (See  <a class="medical medical_review" href="/z/d/html/562.html" rel="external">"Trigger control to enhance asthma management", section on 'Atmospheric conditions'</a>.)</p><p class="headingAnchor" id="H12"><span class="h3">Tobacco smoke</span><span class="headingEndMark"> — </span>Exposure to secondhand cigarette smoke is the single, most common, external risk factor for the development and progression of asthma symptoms in children [<a href="#rid43">43-45</a>]. (See  <a class="medical medical_review" href="/z/d/html/6375.html" rel="external">"Secondhand smoke exposure: Effects in children"</a>.)</p><p class="headingAnchor" id="H2157099537"><span class="h3">Vaping</span><span class="headingEndMark"> — </span>In a laboratory setting, e-cigarette use altered pulmonary function and inflammation in patients with asthma [<a href="#rid46">46</a>]. Adolescents with exposure to secondhand e-cigarette smoke had increased odds of self-reported asthma exacerbations [<a href="#rid47">47,48</a>].</p><p class="headingAnchor" id="H13"><span class="h3">Allergens</span><span class="headingEndMark"> — </span>Indoor and outdoor allergens are an important trigger of childhood asthma for the 80 percent of children with asthma and allergies, particularly those older than three years of age (see  <a class="medical medical_review" href="/z/d/html/530.html" rel="external">"Allergen avoidance in the treatment of asthma and allergic rhinitis"</a>). These include [<a href="#rid49">49</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>House dust mites, cockroaches, and rodents [<a href="#rid50">50-53</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pet exposures; cats and dogs are especially provocative, but other furry animals (gerbils, rabbits, hamsters, etc) may be suspect, especially if symptoms only occur in settings where these animals reside [<a href="#rid54">54</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pollens [<a href="#rid55">55</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Molds</p><p></p><p class="headingAnchor" id="H14"><span class="h3">Irritant exposures</span><span class="headingEndMark"> — </span>Asthma symptoms that occur after prolonged time indoors (eg, winter months or during periods of inclement weather) should raise a suspicion of sensitivity to indoor exposures to allergens (see <a class="local">'Allergens'</a> above) or inhaled airway irritants, such as [<a href="#rid49">49,56</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Nitrogen dioxide (from gas stoves) [<a href="#rid57">57</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Particulates and smoke from wood fires, pellet stoves, or kerosene space heaters</p><p class="bulletIndent1"><span class="glyph">●</span>Exposure to chemicals via vaping</p><p class="bulletIndent1"><span class="glyph">●</span>Propellant cleaning sprays</p><p class="bulletIndent1"><span class="glyph">●</span>Perfumes, hair sprays</p><p class="bulletIndent1"><span class="glyph">●</span>Paint</p><p class="bulletIndent1"><span class="glyph">●</span>Room deodorizers</p><p class="bulletIndent1"><span class="glyph">●</span>Cleaning products with strong odors</p><p></p><p class="headingAnchor" id="H109571282"><span class="h3">Stress</span><span class="headingEndMark"> — </span>Various types of stress can trigger or exacerbate asthma [<a href="#rid58">58</a>], although asthma can also cause stress. However, asthma symptoms and exacerbations should not be attributed to stress unless all other exacerbating factors have been excluded. In addition, asthma should be sufficiently well controlled to allow patients to tolerate stressful situations and other unavoidable triggers without asthma exacerbations.</p><p class="headingAnchor" id="H15"><span class="h2">Additional history</span><span class="headingEndMark"> — </span>Additional history that should be obtained in children with suspected asthma includes a personal history of other atopic diseases, family history of asthma or other atopic diseases (eg, allergic rhinitis, atopic dermatitis, and food allergy), environmental history, past medical history, medication use, medical utilization, school attendance, and psychosocial factors.</p><p class="headingAnchor" id="H16"><span class="h3">Allergic history</span><span class="headingEndMark"> — </span>Allergic disease is associated with the development, severity, and persistence of asthma. As an example, up to 80 percent of children with atopic dermatitis develop asthma and/or allergic rhinitis later in childhood [<a href="#rid59">59</a>]. Approximately 30 percent of children with food allergy have asthma and respiratory allergy compared with 10 percent of children without food allergy [<a href="#rid60">60</a>]. Food allergy is also a risk factor for life-threatening asthma, as evidenced by a substantially higher rate of food allergy in children requiring intubation for asthma compared with a control group of asthmatic children [<a href="#rid61">61</a>]. Sensitivity to many mold allergens is associated with increased asthma severity and persistence [<a href="#rid62">62,63</a>]. (See  <a class="medical medical_review" href="/z/d/html/5545.html" rel="external">"Role of allergy in atopic dermatitis (eczema)"</a> and  <a class="medical medical_review" href="/z/d/html/530.html" rel="external">"Allergen avoidance in the treatment of asthma and allergic rhinitis"</a> and  <a class="medical medical_review" href="/z/d/html/572.html" rel="external">"Risk factors for asthma", section on 'Atopy and allergens'</a>.)</p><p>In a study of children who were hospitalized for wheezing (cases), total serum immunoglobulin E (IgE) concentrations in the subgroup &lt;3 years of age were similar to hospitalized children without wheezing (controls) but were significantly elevated among the cases in the subgroup &gt;3 years old [<a href="#rid25">25</a>]. In addition, a higher percentage of cases were sensitized to at least one inhaled allergen (84 versus 33 percent).</p><p>In atopic infants, sensitization to common foods, such as egg white and cow's milk, may occur and peaks at approximately eight months of age [<a href="#rid64">64</a>]. IgE antibodies to inhalant allergens generally appear beginning at two years of age and increase throughout childhood [<a href="#rid64">64</a>]. Food allergy and eczema are the most common manifestations of atopy in early life, whereas asthma and allergic rhinitis are more common in older children. (See  <a class="medical medical_review" href="/z/d/html/1729.html" rel="external">"Atopic dermatitis (eczema): Pathogenesis, clinical manifestations, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/2398.html" rel="external">"Clinical manifestations of food allergy: An overview"</a> and  <a class="medical medical_review" href="/z/d/html/5745.html" rel="external">"Food allergy in children: Prevalence, natural history, and monitoring for resolution"</a>.)</p><p>Sensitization to foods and the presence of atopic dermatitis represent an atopic diathesis, whereas sensitization to airborne allergens also represents a trigger for asthma exacerbations.</p><p class="headingAnchor" id="H17"><span class="h3">Family history</span><span class="headingEndMark"> — </span>The influence of genetics in the development of asthma has not been fully defined [<a href="#rid45">45,65-71</a>]. Because families also share environments, determining the influence of the genetic contribution to asthma is complicated. Nonetheless, a family history of asthma or other atopic disease (ie, allergic rhinitis, atopic dermatitis, or food allergy) certainly strengthens the likelihood that a child with a compatible history has asthma.</p><p>Children with one asthmatic parent are 2.6 times more likely to have asthma; with two asthmatic parents, the odds ratio rises to 5.2 [<a href="#rid65">65</a>]. Maternal asthma appears to make a bigger contribution than paternal asthma to asthma in offspring, although this finding is inconsistent [<a href="#rid67">67-69</a>].</p><p class="headingAnchor" id="H18"><span class="h3">Environment</span><span class="headingEndMark"> — </span>A thorough review of all regular environments, including home, school, daycare, and relatives' homes, is essential to evaluate possible provocative situations in the child with asthma. The table outlines some questions that may be helpful in obtaining this history  (<a class="graphic graphic_table graphicRef59599" href="/z/d/graphic/59599.html" rel="external">table 6</a>). A strategy to avoid asthma triggers is one of the essential elements for managing the disease. (See  <a class="medical medical_review" href="/z/d/html/562.html" rel="external">"Trigger control to enhance asthma management"</a> and  <a class="medical medical_review" href="/z/d/html/530.html" rel="external">"Allergen avoidance in the treatment of asthma and allergic rhinitis"</a>.)</p><p class="headingAnchor" id="H19"><span class="h3">Past medical history</span><span class="headingEndMark"> — </span>A careful survey of all aspects of the child's medical history is critical to formulate a differential diagnosis of the child's complaint. Questions about the neonatal course, early respiratory symptoms, and the coexistence of systemic symptoms (failure to thrive, fever, developmental delay, recurrent infections) may point toward other diagnoses. Additional questioning may reveal evidence of comorbid conditions, such as obstructive sleep apnea (OSA), gastroesophageal reflux, or chronic rhinosinusitis.</p><p>Sleep disordered breathing, for example, was associated with a 3.6-fold increased risk of severe asthma in one study [<a href="#rid72">72</a>]. Another large, observational study found an improvement in asthma control (eg, decreased exacerbations, hospitalizations, and medication use) following adenotonsillectomy [<a href="#rid73">73</a>]. The latter results did not show, however, that adenotonsillectomy caused a reduction in the severity of childhood asthma. It is possible that the children who underwent adenotonsillectomy shared another unknown factor that led to improvements in their asthma over time, such as a reduction in upper respiratory tract infections. (See <a class="local">'Differential diagnosis'</a> below and  <a class="medical medical_review" href="/z/d/html/564.html" rel="external">"Evaluation of severe asthma in adolescents and adults", section on 'Assessing comorbid conditions'</a>.)</p><p class="headingAnchor" id="H20"><span class="h3">Medications</span><span class="headingEndMark"> — </span>A careful review of prior and present medications (including over-the-counter and alternative remedies) provides information on adherence to therapy, drug efficacy, drug delivery systems in use, accuracy of diagnosis, and control of asthma. Response to treatment with <a class="drug drug_pediatric" data-topicid="13290" href="/z/d/drug information/13290.html" rel="external">albuterol</a>, as demonstrated by a decreased respiratory rate, diminished retractions, increased aeration, and/or decreased cough or wheezing, can be helpful in making the diagnosis of asthma, particularly in children unable to perform spirometry. The onset of action is within 20 minutes, and the benefits should last four to six hours.</p><p>Common reasons for poor response to asthma medications include:</p><p class="bulletIndent1"><span class="glyph">●</span>Nonadherence to the prescribed regimen. Caregivers and children often overreport adherence with controller medications; objective measures (eg, confirmation of pharmacy refill rates or an inhaler with a dose counter) may be necessary to verify adherence [<a href="#rid74">74</a>]. Overuse of quick-relief medications (eg, short-acting beta agonists) with resultant tolerance can also be an issue. (See  <a class="medical medical_review" href="/z/d/html/556.html" rel="external">"Enhancing patient adherence to asthma therapy"</a> and  <a class="medical medical_review" href="/z/d/html/558.html" rel="external">"Beta agonists in asthma: Acute administration and prophylactic use", section on 'Tolerance'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Improper inhaler technique. Since the efficacy of many asthma medications depends upon their deposition in the lung, inhalation technique figures strongly in the success or failure of inhaled therapies. Metered dose inhalers (MDIs) require a significant degree of coordination for optimal drug delivery, and there is considerable evidence that many patients and health care professionals do not regularly perform or teach proper inhalation technique [<a href="#rid75">75,76</a>]. Errors also can be made with dry powder inhalers (DPIs). Patient education materials, use of spacers (with MDIs), and frequent reappraisal of technique contribute to greater success with this form of therapy. Valved holding chambers, otherwise known as spacers, with masks are especially helpful to the very young child. (See  <a class="medical medical_review" href="/z/d/html/5737.html" rel="external">"Delivery of inhaled medication in children"</a> and  <a class="medical medical_review" href="/z/d/html/5738.html" rel="external">"The use of inhaler devices in children"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Ineffective drug dose or dosing interval. (See  <a class="medical medical_review" href="/z/d/html/5744.html" rel="external">"Asthma in children younger than 12 years: Management of persistent asthma with controller therapies"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Complicating medical problems (eg, chronic sinusitis, vocal cord dysfunction, gastroesophageal reflux, environmental allergies) [<a href="#rid77">77,78</a>]. (See  <a class="medical medical_review" href="/z/d/html/7528.html" rel="external">"Chronic rhinosinusitis: Clinical manifestations, pathophysiology, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/523.html" rel="external">"Inducible laryngeal obstruction (paradoxical vocal fold motion)"</a> and  <a class="medical medical_review" href="/z/d/html/5892.html" rel="external">"Clinical manifestations and diagnosis of gastroesophageal reflux disease in children and adolescents"</a> and  <a class="medical medical_review" href="/z/d/html/7536.html" rel="external">"Relationships between rhinosinusitis and asthma"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Complicating psychosocial factors (which can interfere with regularly obtaining and properly using medications).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Inappropriate treatment (eg, antibiotics, antitussives, over-the-counter or alternative medications).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Different response to controller medications depending upon the child's intrinsic characteristics [<a href="#rid79">79-82</a>].</p><p></p><p class="headingAnchor" id="H21"><span class="h3">Health care utilization</span><span class="headingEndMark"> — </span>The degree of asthma control is usually linked to health care utilization, such that more severe or poorly controlled patients with asthma tend to be treated more often in EDs, urgent care centers, or doctors' offices. A history of more than a few such interventions is often indicative of poorly controlled asthma, regardless of the level of chronic symptoms [<a href="#rid83">83</a>]. In addition, a history of prior hospitalizations, ED visits, or exacerbations requiring oral glucocorticoids confers an increased risk for future asthma exacerbations.</p><p class="headingAnchor" id="H22"><span class="h3">School attendance</span><span class="headingEndMark"> — </span>One-third of children with asthma suffer noticeable disability [<a href="#rid84">84</a>]. Interference with regular school attendance or achievement is a good measure of disability from childhood asthma. A pattern of significant numbers of lost days from school and a deteriorating academic performance should prompt more aggressive asthma management.</p><p>Nearly 14 million school days are missed each year due to asthma, although the percent of children with asthma who reported one or more missed school days declined significantly from 2003 to 2013 (61.4 versus 49 percent) [<a href="#rid3">3</a>] and held steady at 49 percent in 2016 [<a href="#rid10">10</a>]. Childhood asthma is also a major cause of parent/caregiver work absenteeism [<a href="#rid85">85,86</a>].</p><p class="headingAnchor" id="H23"><span class="h3">Physical activity</span><span class="headingEndMark"> — </span>Most children with asthma can have symptoms brought on by intensive activity; therefore, many children limit their level of exertion. In one study, children with newly diagnosed, untreated asthma were less fit and spent less time in vigorous activity than their healthy peers [<a href="#rid87">87</a>]. However, physical activities need not be restricted. Rather, appropriate treatment should allow full participation, which should be encouraged. With appropriate therapy, children with asthma can participate in all activities, including sports at every level up to and including participation in the Olympics [<a href="#rid88">88</a>], without restriction.</p><p class="headingAnchor" id="H24"><span class="h3">Psychosocial profile</span><span class="headingEndMark"> — </span>Chronic asthma may create or exacerbate psychosocial problems for patients and their caregivers. Conversely, psychosocial factors can affect asthma symptoms and health behaviors [<a href="#rid89">89</a>]. Stressors surrounding asthma can include:</p><p class="bulletIndent1"><span class="glyph">●</span>Anxiety about the often sudden, life-threatening nature of attacks</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Fear of dying</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Fear of peer rejection because of being "different"</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Concern regarding the adverse effects of asthma drugs (particularly glucocorticoids, also called corticosteroids)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Sleep deprivation due to nocturnal symptoms</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Poor school performance</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Financial consequences</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Disruption in family routines</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Siblings' resentment of the patient’s special status within the family</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Limitation of social or geographic venues because of potential triggering of asthma (eg, cannot visit places where environmental tobacco smoke or allergen exposure is likely)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Family discord over asthma treatment</p><p></p><p class="headingAnchor" id="H1097776"><span class="h2">Predictive tools</span><span class="headingEndMark"> — </span>Parents/caregivers often ask if their young children with recurrent cough or wheeze have asthma and if they might outgrow it. Various predictive models or clinical indicators of risk have been studied to help the clinician identify young children who will continue wheezing later in childhood, although these tools were primarily designed to enrich study populations rather than actually predict asthma. These models have employed various risk factors associated with the development of asthma in longitudinal epidemiologic studies, such as baseline forced expiratory volume in the first second (FEV<sub>1</sub>)/forced vital capacity (FVC), parental history of allergic sensitization and asthma, wheezing history, atopic disease in the child, IgE levels, and cytokine secretion profiles. However, none of these clinical tools have been validated in populations different from the study group. These tools and risk factors are discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/13585.html" rel="external">"Wheezing phenotypes and prediction of asthma in young children", section on 'Predictive tools in children with wheezing'</a> and  <a class="medical medical_review" href="/z/d/html/567.html" rel="external">"Natural history of asthma", section on 'Infants and children'</a>.)</p><p class="headingAnchor" id="H25"><span class="h1">PHYSICAL EXAMINATION</span><span class="headingEndMark"> — </span>Examination findings during an acute exacerbation include tachypnea, hypoxia, wheezing, accessory muscle use, retractions, and prolonged expiratory phase. These findings are discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/5740.html" rel="external">"Acute asthma exacerbations in children younger than 12 years: Emergency department management"</a>.)</p><p>Physical examination of a child with asthma is generally normal if performed when the patient does not have an acute exacerbation. Abnormal findings in the absence of an acute exacerbation may suggest severe disease, suboptimal control, or associated atopic conditions. Abnormalities that may be observed include [<a href="#rid83">83</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Decreased air entry or wheezing on auscultation</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A prolonged expiratory phase on auscultation</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Dry cough</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Signs of rhinitis, conjunctivitis, and sinusitis (nasal discharge, inflamed nasal mucosa, Dennie-Morgan lines, transverse nasal crease, sinus tenderness, dark circles under the eyes) (see  <a class="medical medical_review" href="/z/d/html/7528.html" rel="external">"Chronic rhinosinusitis: Clinical manifestations, pathophysiology, and diagnosis"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Signs of an acute respiratory infection</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Halitosis due to chronic rhinitis, sinusitis, and mouth breathing</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Eczema/atopic dermatitis</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Nasal polyps  (<a class="graphic graphic_picture graphicRef50105" href="/z/d/graphic/50105.html" rel="external">picture 1</a> and <a class="graphic graphic_picture graphicRef73419" href="/z/d/graphic/73419.html" rel="external">picture 2</a>) (glistening, gray, mucoid masses within the nasal cavities, which may be associated with asthma and <a class="drug drug_pediatric" data-topicid="12829" href="/z/d/drug information/12829.html" rel="external">aspirin</a> sensitivity in adolescents and adults, but should prompt evaluation for cystic fibrosis and primary ciliary dyskinesia in children of any age) (see  <a class="medical medical_review" href="/z/d/html/6367.html" rel="external">"Cystic fibrosis: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/4338.html" rel="external">"Primary ciliary dyskinesia (immotile-cilia syndrome)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>An increased anterior-posterior diameter of the chest due to air trapping</p><p></p><p class="headingAnchor" id="H73439781"><span class="h2">Obesity</span><span class="headingEndMark"> — </span>Results are conflicting regarding the relationship between obesity and asthma severity [<a href="#rid72">72,90-93</a>]. Obesity and higher percent body fat are associated with an increased incidence of asthma [<a href="#rid94">94</a>] and are more commonly seen in children with newly diagnosed, untreated asthma than their healthy peers [<a href="#rid87">87</a>]. Higher body mass index (BMI) is also associated with greater asthma severity [<a href="#rid90">90,94</a>]. However, biologic causality has not been proven, and reverse causation may also occur (ie, asthma limiting physical activity leading to obesity). (See  <a class="medical medical_review" href="/z/d/html/572.html" rel="external">"Risk factors for asthma"</a> and  <a class="medical medical_review" href="/z/d/html/564.html" rel="external">"Evaluation of severe asthma in adolescents and adults", section on 'Assessing comorbid conditions'</a>.)</p><p class="headingAnchor" id="H27"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>A history of intermittent or chronic symptoms typical of asthma plus the finding on physical examination of characteristic musical wheezing (present in association with symptoms and absent when symptoms resolve) strongly point to a diagnosis of asthma (see <a class="local">'History'</a> above and <a class="local">'Physical examination'</a> above). Confirmation of the diagnosis of asthma is based on three key additional elements [<a href="#rid83">83,95,96</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>The demonstration of variable expiratory airflow limitation, preferably by spirometry, when possible</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Documentation of reversible obstruction</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Exclusion of alternative diagnoses (see <a class="local">'Differential diagnosis'</a> below)</p><p></p><p>Evidence of airway obstruction on spirometry, especially if acutely reversible with a bronchodilator, strongly supports the diagnosis of asthma. However, normal spirometry, or the lack of reversibility of obstruction in the setting of an acute exacerbation, does not exclude the diagnosis. A trial of asthma medication is warranted in patients with symptoms suggestive of asthma who have normal or near-normal spirometry or who are unable to perform spirometry due to age or other factors. Improvement on medications is sufficient to make the diagnosis in these patients. If a trial of asthma medication fails to improve symptoms, bronchoprovocation testing with <a class="drug drug_pediatric" data-topicid="126558" href="/z/d/drug information/126558.html" rel="external">methacholine</a>, cold air, or exercise may be warranted. (See <a class="local">'Spirometry'</a> below and <a class="local">'Medications'</a> above and <a class="local">'Ancillary studies'</a> below.)</p><p class="headingAnchor" id="H28"><span class="h2">Spirometry</span><span class="headingEndMark"> — </span>Demonstration of reversible airflow obstruction establishes the diagnosis of asthma and facilitates the assessment of severity  (<a class="graphic graphic_figure graphicRef73165" href="/z/d/graphic/73165.html" rel="external">figure 1</a>) [<a href="#rid83">83</a>]. Spirometry is the preferred method of diagnosis of airflow obstruction. The National Asthma Education and Prevention Program (NAEPP) expert panel recommends performing spirometry in patients five years of age and older if a diagnosis of asthma is suspected [<a href="#rid83">83</a>]. (See  <a class="medical medical_review" href="/z/d/html/5735.html" rel="external">"Overview of pulmonary function testing in children"</a>.)</p><p>Spirometry measurements include forced vital capacity (FVC) and the forced expiratory volume in the first second (FEV<sub>1</sub>). Airflow obstruction is defined as FEV<sub>1</sub> reduced to less than 80 percent predicted and an FEV<sub>1</sub>/FVC ratio of less than 0.85 (85 percent)  (<a class="graphic graphic_table graphicRef51579" href="/z/d/graphic/51579.html" rel="external">table 7A</a>). Reference values are based on age, height, sex, and race [<a href="#rid97">97</a>]. FEV<sub>1</sub>/FVC appears to be a more sensitive measure of <strong>impairment</strong> than FEV<sub>1</sub>, whereas FEV<sub>1</sub> may be a more useful measure of <strong>risk</strong> for future exacerbations [<a href="#rid83">83,98-101</a>] (see  <a class="medical medical_review" href="/z/d/html/90904.html" rel="external">"Asthma in children younger than 12 years: Overview of initiating therapy and monitoring control", section on 'Assessment of control'</a>). Forced expiratory flow between 25 and 75 percent of vital capacity (FEF25-75) less than 65 percent correlates with reversible airflow obstruction in children with normal FEV<sub>1</sub> and may be a useful measure in this subgroup, although further studies are needed [<a href="#rid102">102</a>].</p><p>Spirometry should be performed before and after administration of a bronchodilator to assess for reversibility (bronchodilator response [BDR]) even in children with a normal baseline FEV<sub>1</sub> because many of these children will still have a BDR (both within the normal range and sometimes also supranormal) after treatment. Significant reversibility is indicated by an increase in FEV<sub>1</sub> of ≥12 percent from baseline after administration of a short-acting bronchodilator. This definition for BDR positivity was established primarily in adults. An increase in FEV<sub>1</sub> of ≥8 percent may be a better definition for BDR in children [<a href="#rid103">103-105</a>]. (See  <a class="medical medical_review" href="/z/d/html/5735.html" rel="external">"Overview of pulmonary function testing in children"</a>.)</p><p>There is some evidence from cross-sectional studies to suggest that the NAEPP criteria for percent predicted FEV<sub>1</sub>  (<a class="graphic graphic_table graphicRef51579 graphicRef73634" href="/z/d/graphic/51579.html" rel="external">table 7A-B</a>) do not accurately categorize asthma severity in children and that symptom frequency and rescue medication use may be more sensitive measures [<a href="#rid98">98,99,106-108</a>]. In the Childhood Asthma Management Program (CAMP) study, for example, the mean FEV<sub>1</sub> of all children studied was 94 percent predicted [<a href="#rid99">99</a>], although this study included only children with mild-to-moderate asthma based upon symptoms, use of medications, and response to <a class="drug drug_pediatric" data-topicid="126558" href="/z/d/drug information/126558.html" rel="external">methacholine</a> [<a href="#rid109">109</a>]. Nonetheless, percent predicted FEV<sub>1</sub> remains a useful measure because it is strongly associated with the risk of asthma exacerbation in the 12 months after measurement [<a href="#rid100">100,101</a>].</p><p>Another potential spirometric measure of risk for asthma severity and poor control (asthma instability) is the air-trapping obstruction phenotype, defined as a FVC Z-score of &lt;-1.64 (equivalent to fifth percentile in a healthy population) or a ≥10 percent change in the predicted value of FVC after bronchodilation. In a study of 560 children aged 6 to 17 years from low-income, urban areas who had physician-diagnosed asthma, the risk of ≥2 asthma exacerbations during the 12-month study period was more than fourfold higher (odds ratio 4.41, 95% CI 2.37-8.21) in those with this phenotype compared with those without any evidence of obstruction on spirometry [<a href="#rid110">110</a>]. Children with the air-trapping obstruction phenotype also had higher Composite Asthma Severity Index scores and asthma treatment steps, as well as greater sensitivity to <a class="drug drug_pediatric" data-topicid="126558" href="/z/d/drug information/126558.html" rel="external">methacholine</a> challenge and variability in FEV<sub>1</sub> over time.</p><p>Measurements of peak expiratory flow using a peak flow meter are more variable and effort dependent than spirometry. In addition, there is wide variability in the published predicted peak expiratory flow reference values and in the reference values from brand to brand [<a href="#rid83">83</a>]. Thus, peak flow measurements alone should not be used to diagnose asthma. Peak flow measurements may be more useful in monitoring a patient's symptoms and response to therapy over time, although serial spirometry is preferred  (<a class="graphic graphic_table graphicRef73634" href="/z/d/graphic/73634.html" rel="external">table 7B</a>) [<a href="#rid83">83</a>]. (See  <a class="medical medical_review" href="/z/d/html/568.html" rel="external">"Peak expiratory flow monitoring in asthma"</a>.)</p><p class="headingAnchor" id="H29"><span class="h2">Children &lt;5 years</span><span class="headingEndMark"> — </span>In infants and children younger than five years of age, the diagnostic steps should remain the same as described above, except that spirometry often cannot be performed in this age group. A trial of asthma medications may help to establish the diagnosis in these children. Reversal of symptoms and signs in the time expected for <a class="drug drug_pediatric" data-topicid="13290" href="/z/d/drug information/13290.html" rel="external">albuterol</a> to work is suggestive of the diagnosis of asthma. Impulse oscillometry (IOS) is an alternative to spirometry in younger children since it only requires passive cooperation [<a href="#rid111">111-113</a>]. However, it is not readily available to most clinicians treating children with asthma, limiting its clinical utility [<a href="#rid114">114</a>]. IOS measurements at baseline and postbronchodilator differed significantly between children aged three to six years with and without asthma, whereas no significant differences were seen with traditional spirometry [<a href="#rid115">115-117</a>]. IOS may detect alterations in respiratory mechanics not seen with spirometry even in older children [<a href="#rid118">118-120</a>]. (See <a class="local">'Diagnosis'</a> above and <a class="local">'Medications'</a> above.)</p><p>Debate is ongoing regarding how to best classify infants and young children with recurrent wheezing. The terms asthma, reactive airway disease, wheezy bronchitis, bronchiolitis, asthmatic bronchitis, wheezing-associated respiratory illness, and postinfectious bronchial hyperreactivity have all been employed. This jargon reflects an attempt to describe and define a subgroup of wheezing children with a more transient disorder than is implied by "asthma," which is, by definition, chronic. "Wheezy bronchitis" usually defines nonatopic babies or toddlers with recurrent, virus-induced wheezing (the majority of this group of wheezing young children) that tends to disappear by five years of age [<a href="#rid121">121,122</a>]. Asthma, on the other hand, has been taken to mean a chronic condition, frequently associated with atopy, provoked by a number of triggers in addition to viruses, and carrying a decreased likelihood for spontaneous resolution. (See  <a class="medical medical_review" href="/z/d/html/543.html" rel="external">"Asthma in adolescents and adults: Evaluation and diagnosis", section on 'Definition'</a> and  <a class="medical medical_review" href="/z/d/html/567.html" rel="external">"Natural history of asthma", section on 'Infants and children'</a> and  <a class="medical medical_review" href="/z/d/html/13585.html" rel="external">"Wheezing phenotypes and prediction of asthma in young children"</a> and  <a class="medical medical_review" href="/z/d/html/535.html" rel="external">"Role of viruses in wheezing and asthma: An overview"</a> and  <a class="medical medical_review" href="/z/d/html/5752.html" rel="external">"Evaluation of wheezing in infants and children"</a> and  <a class="medical medical_review" href="/z/d/html/6343.html" rel="external">"Approach to chronic cough in children"</a>.)</p><p class="headingAnchor" id="H30"><span class="h2">Ancillary studies</span><span class="headingEndMark"> — </span>The history and physical examination, in conjunction with spirometry, are usually adequate to establish the diagnosis of asthma. Ancillary studies are most helpful to exclude competing diagnoses or to identify comorbid conditions.</p><p class="headingAnchor" id="H9440209"><span class="h3">Allergy testing</span><span class="headingEndMark"> — </span>Allergy testing, done either by skin or in vitro testing, is helpful even in the very young child when used selectively. Specifically, when the environmental history uncovers exposure to furry animals (pets or pests), molds, cockroaches, or dust mites, it is worthwhile to test for these or other limited allergens to formulate proper avoidance strategies. Outdoor aeroallergens are unusual triggers in infants and very young children but may be triggers in older children. Food allergy testing is not helpful unless there is a sound history of gastrointestinal complaints, worsening eczema, urticaria, shortness of breath, throat tightness, cough, hoarse voice, or asthma that is temporally associated with the ingestion of certain foods. Children with this type of history should be evaluated by a clinician familiar with food allergies and prescribed epinephrine since ingestion of a food allergen can be life threating in a patient with food allergies, particularly in a patient with concomitant asthma. In addition, when indicated testing reveals the presence of IgE antibody to any allergen, an atopic diathesis is demonstrated, increasing the likelihood that chest symptoms are due to asthma. (See  <a class="medical medical_review" href="/z/d/html/5541.html" rel="external">"Overview of skin testing for IgE-mediated allergic disease"</a>.)</p><p class="headingAnchor" id="H259647576"><span class="h3">Exhaled nitric oxide</span><span class="headingEndMark"> — </span>Measurement of the fraction of exhaled nitric oxide (FE<sub>NO</sub>) may be used as an adjunct to other assessments when the diagnosis of asthma is uncertain [<a href="#rid123">123</a>]. The use of this test in diagnosing asthma is discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/542.html" rel="external">"Exhaled nitric oxide analysis and applications", section on 'Clinical use of FENO in asthma'</a>.)</p><p class="headingAnchor" id="H9440215"><span class="h3">Bronchoprovocation testing</span><span class="headingEndMark"> — </span>We advise performing bronchoprovocation testing (with <a class="drug drug_pediatric" data-topicid="126558" href="/z/d/drug information/126558.html" rel="external">methacholine</a>, cold air, or exercise) when the clinical features are suggestive of asthma but spirometry is normal and there is no significant response to asthma medications. An exercise challenge of sufficient magnitude may provoke symptoms in children with asthma [<a href="#rid124">124-126</a>]. A negative bronchoprovocation study may also be useful in reducing the likelihood that a child has asthma, although it cannot be used to exclude the diagnosis. For safety reasons, these tests should be conducted in a specialized facility with trained technicians and should not be performed if a patient has severe airflow limitation (FEV<sub>1</sub> &lt;50 percent predicted) [<a href="#rid127">127</a>]. Exercise challenge has a high specificity, whereas methacholine challenge had a high sensitivity. Bronchial challenge tests are discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/5735.html" rel="external">"Overview of pulmonary function testing in children"</a> and  <a class="medical medical_review" href="/z/d/html/525.html" rel="external">"Bronchoprovocation testing"</a>.)</p><p class="headingAnchor" id="H9440221"><span class="h3">Chest radiograph</span><span class="headingEndMark"> — </span>We advise performing a chest radiograph (chest x-ray [CXR]) only in children who do not respond to initial therapy. In those children, the chest radiograph may display findings suggestive of causes for wheezing other than asthma including congenital malformations (eg, a right aortic arch suggestive of a vascular ring); evidence of airspace disease consistent with aspiration or cystic fibrosis; or findings consistent with asthma, such as hyperinflation, peribronchial thickening, and mucoid impaction with atelectasis.</p><p class="headingAnchor" id="H9440227"><span class="h3">Sweat chloride test</span><span class="headingEndMark"> — </span>A sweat chloride test below established cut-off values reduces the likelihood of the diagnosis of cystic fibrosis in children with respiratory complaints often in association with frequent foul-smelling stools or other evidence of malabsorption (eg, undigested food or oil), recurrent pneumonia, edema, and/or failure to thrive. There should be a low threshold to perform this test in children with this clinical picture, even if prenatal maternal screening or newborn screening was negative, since identifying a patient with cystic fibrosis has major implications for the patient, the family, and future reproductive decisions. Mutation analysis should be performed even if the sweat chloride is below established cut-off values if the suspicion for cystic fibrosis remains high. (See  <a class="medical medical_review" href="/z/d/html/6367.html" rel="external">"Cystic fibrosis: Clinical manifestations and diagnosis"</a>.)</p><p class="headingAnchor" id="H9440233"><span class="h3">Barium swallow</span><span class="headingEndMark"> — </span>A modified <a class="drug drug_pediatric" data-topicid="118048" href="/z/d/drug information/118048.html" rel="external">barium</a> swallow should be included in the diagnostic evaluation if swallowing dysfunction with aspiration is a consideration. (See  <a class="medical medical_review" href="/z/d/html/5892.html" rel="external">"Clinical manifestations and diagnosis of gastroesophageal reflux disease in children and adolescents"</a> and  <a class="medical medical_review" href="/z/d/html/5752.html" rel="external">"Evaluation of wheezing in infants and children"</a>.)</p><p class="headingAnchor" id="H7555157"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>Although wheezing is most commonly caused by asthma, it is not a pathognomonic finding. The lack of objective measures of pulmonary function in very young children and the relatively high prevalence of congenital infections and inherited disorders that present with wheezing make it imperative to consider the differential diagnosis of wheezing illnesses before making a diagnosis of asthma solely on the basis of wheezing  (<a class="graphic graphic_table graphicRef67370" href="/z/d/graphic/67370.html" rel="external">table 1</a> and <a class="graphic graphic_table graphicRef62889" href="/z/d/graphic/62889.html" rel="external">table 2</a>). In particular, other causes of wheezing in children must be excluded if there is a failure to respond to asthma therapy or if the history and/or physical examination suggest alternative diagnoses. Cough is the primary manifestation in some children with asthma; therefore, the differential diagnosis for chronic cough in children should also be considered  (<a class="graphic graphic_table graphicRef75873" href="/z/d/graphic/75873.html" rel="external">table 8</a> and <a class="graphic graphic_algorithm graphicRef113691" href="/z/d/graphic/113691.html" rel="external">algorithm 1</a>). Clinical features suggestive of a diagnosis other than asthma are seen in the table  (<a class="graphic graphic_table graphicRef70442" href="/z/d/graphic/70442.html" rel="external">table 9</a>) and are discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/5752.html" rel="external">"Evaluation of wheezing in infants and children"</a> and  <a class="medical medical_review" href="/z/d/html/6343.html" rel="external">"Approach to chronic cough in children"</a> and  <a class="medical medical_review" href="/z/d/html/6356.html" rel="external">"Causes of chronic cough in children"</a>.)</p><p class="headingAnchor" id="H7557096"><span class="h1">INDICATIONS FOR REFERRAL</span><span class="headingEndMark"> — </span>Consultation with an asthma specialist, typically either a pulmonologist or an allergist, is warranted when the diagnosis of asthma is uncertain, the asthma is difficult to control, medication side effects are problematic, or a patient has frequent exacerbations. Pulmonologists may be most helpful if alternative pulmonary diseases are suspected or if further pulmonary testing or bronchoscopy may be needed. Referral to an allergist may be most helpful if allergic triggers need further evaluation if food allergy is suspected or if concomitant nasal and ocular allergy symptoms are difficult to control.</p><p class="headingAnchor" id="H804816909"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/113453.html" rel="external">"Society guideline links: Asthma in children"</a>.)</p><p class="headingAnchor" id="H33"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/z/d/html/16897.html" rel="external">"Patient education: Cough in children (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/z/d/html/1222.html" rel="external">"Patient education: Asthma symptoms and diagnosis in children (Beyond the Basics)"</a> and  <a class="medical medical_patient" href="/z/d/html/1172.html" rel="external">"Patient education: Asthma treatment in children (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H34"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Overview of approach to diagnosis </strong>– Establishing a diagnosis of asthma involves a careful process of history taking, physical examination, and diagnostic studies; other causes of wheezing and/or cough must be excluded  (<a class="graphic graphic_table graphicRef67370" href="/z/d/graphic/67370.html" rel="external">table 1</a> and <a class="graphic graphic_table graphicRef62889" href="/z/d/graphic/62889.html" rel="external">table 2</a> and <a class="graphic graphic_table graphicRef113206" href="/z/d/graphic/113206.html" rel="external">table 3</a> and <a class="graphic graphic_algorithm graphicRef113691" href="/z/d/graphic/113691.html" rel="external">algorithm 1</a>). (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>History</strong> – The history in a child with suspected asthma centers on the presence of symptoms (cough and wheeze are the most common), precipitating factors or conditions  (<a class="graphic graphic_table graphicRef79182" href="/z/d/graphic/79182.html" rel="external">table 4</a> and <a class="graphic graphic_table graphicRef80507" href="/z/d/graphic/80507.html" rel="external">table 5</a>), typical symptom patterns, and response to asthma therapy. (See <a class="local">'History'</a> above.)</p><p></p><p class="bulletIndent1">Additional history that should be obtained in children with suspected asthma includes a history of atopy, family history of asthma, environmental history, and past medical history. (See <a class="local">'Additional history'</a> above.)</p><p></p><p class="bulletIndent1">Important aspects of the history in a child with asthma who presents for monitoring include previous and current therapy, exposure to triggers, medical utilization, school attendance and performance, comorbidities, and psychosocial stressors. (See <a class="local">'Additional history'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Physical examination</strong> – The physical examination of a child with asthma is generally normal if performed in the absence of an acute exacerbation. Abnormal findings may suggest severe disease, suboptimal control, or associated atopic conditions. (See <a class="local">'Physical examination'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis </strong>– The diagnosis of asthma requires a history of episodic symptoms of airflow obstruction or bronchial hyperresponsiveness  (<a class="graphic graphic_table graphicRef79182" href="/z/d/graphic/79182.html" rel="external">table 4</a>), demonstration (with spirometry if possible) that airflow obstruction is reversible  (<a class="graphic graphic_figure graphicRef73165" href="/z/d/graphic/73165.html" rel="external">figure 1</a>), and exclusion of alternate diagnoses. If spirometry cannot be performed, a trial of medications may help to establish reversibility. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential diagnosis</strong> – Other causes of wheezing in children must be excluded if there is a failure to respond to asthma therapy or if the history and/or physical examination suggest alternative diagnoses  (<a class="graphic graphic_table graphicRef67370" href="/z/d/graphic/67370.html" rel="external">table 1</a> and <a class="graphic graphic_table graphicRef62889" href="/z/d/graphic/62889.html" rel="external">table 2</a> and <a class="graphic graphic_table graphicRef75873" href="/z/d/graphic/75873.html" rel="external">table 8</a> and <a class="graphic graphic_algorithm graphicRef113691" href="/z/d/graphic/113691.html" rel="external">algorithm 1</a> and <a class="graphic graphic_table graphicRef70442" href="/z/d/graphic/70442.html" rel="external">table 9</a>). (See <a class="local">'Differential diagnosis'</a> above and  <a class="medical medical_review" href="/z/d/html/5752.html" rel="external">"Evaluation of wheezing in infants and children"</a>.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Masoli M, Fabian D, Holt S, et al. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004; 59:469.</a></li><li class="breakAll">Global Initiative for Asthma (GINA). Global Burden of Asthma Report available online. www.ginasthma.org.</li><li class="breakAll">Data from yearly National Health Interview Survey. National Center for Health Statistics. US Department of Health and Human Services. Centers for Disease Control and Prevention. http://www.cdc.gov/asthma/most_recent_data.htm (Accessed on December 04, 2020).</li><li><a class="nounderline abstract_t">Lai CK, Beasley R, Crane J, et al. Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 2009; 64:476.</a></li><li><a class="nounderline abstract_t">Anandan C, Nurmatov U, van Schayck OC, Sheikh A. Is the prevalence of asthma declining? Systematic review of epidemiological studies. Allergy 2010; 65:152.</a></li><li><a class="nounderline abstract_t">Stern J, Pier J, Litonjua AA. Asthma epidemiology and risk factors. Semin Immunopathol 2020; 42:5.</a></li><li class="breakAll">Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention (2022 update). https://ginasthma.org/wp-content/uploads/2022/07/GINA-Main-Report-2022-FINAL-22-07-01-WMS.pdf (Accessed on October 13, 2023).</li><li><a class="nounderline abstract_t">Huang C, Liu W, Hu Y, et al. Updated prevalences of asthma, allergy, and airway symptoms, and a systematic review of trends over time for childhood asthma in Shanghai, China. PLoS One 2015; 10:e0121577.</a></li><li><a class="nounderline abstract_t">Akinbami LJ, Simon AE, Rossen LM. Changing Trends in Asthma Prevalence Among Children. Pediatrics 2016; 137.</a></li><li><a class="nounderline abstract_t">Zahran HS, Bailey CM, Damon SA, et al. Vital Signs: Asthma in Children - United States, 2001-2016. MMWR Morb Mortal Wkly Rep 2018; 67:149.</a></li><li><a class="nounderline abstract_t">Almqvist C, Worm M, Leynaert B, working group of GA2LEN WP 2.5 Gender. Impact of gender on asthma in childhood and adolescence: a GA2LEN review. Allergy 2008; 63:47.</a></li><li><a class="nounderline abstract_t">Anthracopoulos MB, Pandiora A, Fouzas S, et al. Sex-specific trends in prevalence of childhood asthma over 30 years in Patras, Greece. Acta Paediatr 2011; 100:1000.</a></li><li><a class="nounderline abstract_t">Zilmer M, Steen NP, Zachariassen G, et al. Prevalence of asthma and bronchial hyperreactivity in Danish schoolchildren: no change over 10 years. Acta Paediatr 2011; 100:385.</a></li><li><a class="nounderline abstract_t">Wennergren G, Ekerljung L, Alm B, et al. Asthma in late adolescence--farm childhood is protective and the prevalence increase has levelled off. Pediatr Allergy Immunol 2010; 21:806.</a></li><li><a class="nounderline abstract_t">Zöllner IK, Weiland SK, Piechotowski I, et al. No increase in the prevalence of asthma, allergies, and atopic sensitisation among children in Germany: 1992-2001. Thorax 2005; 60:545.</a></li><li><a class="nounderline abstract_t">Osman M, Tagiyeva N, Wassall HJ, et al. Changing trends in sex specific prevalence rates for childhood asthma, eczema, and hay fever. Pediatr Pulmonol 2007; 42:60.</a></li><li><a class="nounderline abstract_t">Marchant JM, Masters IB, Taylor SM, et al. Evaluation and outcome of young children with chronic cough. Chest 2006; 129:1132.</a></li><li><a class="nounderline abstract_t">Johnson D, Osborn LM. Cough variant asthma: a review of the clinical literature. J Asthma 1991; 28:85.</a></li><li><a class="nounderline abstract_t">Wasserfallen JB, Schaller MD, Feihl F, Perret CH. Sudden asphyxic asthma: a distinct entity? Am Rev Respir Dis 1990; 142:108.</a></li><li><a class="nounderline abstract_t">Saetta M, Thiene G, Crescioli S, Fabbri LM. Fatal asthma in a young patient with severe bronchial hyperresponsiveness but stable peak flow records. Eur Respir J 1989; 2:1008.</a></li><li><a class="nounderline abstract_t">Maffei FA, van der Jagt EW, Powers KS, et al. Duration of mechanical ventilation in life-threatening pediatric asthma: description of an acute asphyxial subgroup. Pediatrics 2004; 114:762.</a></li><li><a class="nounderline abstract_t">Brémont F. [From asthma attack to fatal asthma in children]. Arch Pediatr 2004; 11 Suppl 2:86s.</a></li><li><a class="nounderline abstract_t">Schmitz T, von Kries R, Wjst M, Schuster A. A nationwide survey in Germany on fatal asthma and near-fatal asthma in children: different entities? Eur Respir J 2000; 16:845.</a></li><li><a class="nounderline abstract_t">Gern JE. Viral respiratory infection and the link to asthma. Pediatr Infect Dis J 2008; 27:S97.</a></li><li><a class="nounderline abstract_t">Heymann PW, Carper HT, Murphy DD, et al. Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing. J Allergy Clin Immunol 2004; 114:239.</a></li><li><a class="nounderline abstract_t">Tarlo SM, Broder I, Corey P, et al. A case-control study of the role of cold symptoms and other historical triggering factors in asthma exacerbations. Can Respir J 2000; 7:42.</a></li><li><a class="nounderline abstract_t">Johnston NW, Johnston SL, Norman GR, et al. The September epidemic of asthma hospitalization: school children as disease vectors. J Allergy Clin Immunol 2006; 117:557.</a></li><li><a class="nounderline abstract_t">Virant FS. Sinusitis and pediatric asthma. Pediatr Ann 2000; 29:434.</a></li><li><a class="nounderline abstract_t">Tsao CH, Chen LC, Yeh KW, Huang JL. Concomitant chronic sinusitis treatment in children with mild asthma: the effect on bronchial hyperresponsiveness. Chest 2003; 123:757.</a></li><li><a class="nounderline abstract_t">Biscardi S, Lorrot M, Marc E, et al. Mycoplasma pneumoniae and asthma in children. Clin Infect Dis 2004; 38:1341.</a></li><li><a class="nounderline abstract_t">Emre U, Roblin PM, Gelling M, et al. The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch Pediatr Adolesc Med 1994; 148:727.</a></li><li><a class="nounderline abstract_t">Webley WC, Salva PS, Andrzejewski C, et al. The bronchial lavage of pediatric patients with asthma contains infectious Chlamydia. Am J Respir Crit Care Med 2005; 171:1083.</a></li><li><a class="nounderline abstract_t">Guill M. Exercise-induced bronchospasm in children: effects and therapies. Pediatr Ann 1996; 25:146.</a></li><li><a class="nounderline abstract_t">Anderson SD. Indirect challenge tests: Airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest 2010; 138:25S.</a></li><li><a class="nounderline abstract_t">Milgrom H, Taussig LM. Keeping children with exercise-induced asthma active. Pediatrics 1999; 104:e38.</a></li><li><a class="nounderline abstract_t">Godfrey S, Bar-Yishay E. Exercised-induced asthma revisited. Respir Med 1993; 87:331.</a></li><li><a class="nounderline abstract_t">Sano F, Solé D, Naspitz CK. Prevalence and characteristics of exercise-induced asthma in children. Pediatr Allergy Immunol 1998; 9:181.</a></li><li><a class="nounderline abstract_t">Beggs S, Foong YC, Le HC, et al. Swimming training for asthma in children and adolescents aged 18 years and under. Cochrane Database Syst Rev 2013; :CD009607.</a></li><li><a class="nounderline abstract_t">Uyan ZS, Carraro S, Piacentini G, Baraldi E. Swimming pool, respiratory health, and childhood asthma: should we change our beliefs? Pediatr Pulmonol 2009; 44:31.</a></li><li><a class="nounderline abstract_t">Font-Ribera L, Villanueva CM, Nieuwenhuijsen MJ, et al. Swimming pool attendance, asthma, allergies, and lung function in the Avon Longitudinal Study of Parents and Children cohort. Am J Respir Crit Care Med 2011; 183:582.</a></li><li><a class="nounderline abstract_t">Piacentini GL, Baraldi E. Pro: swimming in chlorinated pools and risk of asthma: we can now carry on sending our children to swimming pools! Am J Respir Crit Care Med 2011; 183:569.</a></li><li><a class="nounderline abstract_t">Bernard A, Voisin C, Sardella A. Con: respiratory risks associated with chlorinated swimming pools: a complex pattern of exposure and effects. Am J Respir Crit Care Med 2011; 183:570.</a></li><li><a class="nounderline abstract_t">Cook DG, Strachan DP. Health effects of passive smoking. 3. Parental smoking and prevalence of respiratory symptoms and asthma in school age children. Thorax 1997; 52:1081.</a></li><li><a class="nounderline abstract_t">Mannino DM, Moorman JE, Kingsley B, et al. Health effects related to environmental tobacco smoke exposure in children in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Pediatr Adolesc Med 2001; 155:36.</a></li><li><a class="nounderline abstract_t">Young S, Le Souëf PN, Geelhoed GC, et al. The influence of a family history of asthma and parental smoking on airway responsiveness in early infancy. N Engl J Med 1991; 324:1168.</a></li><li><a class="nounderline abstract_t">Kotoulas SC, Pataka A, Domvri K, et al. Acute effects of e-cigarette vaping on pulmonary function and airway inflammation in healthy individuals and in patients with asthma. Respirology 2020; 25:1037.</a></li><li><a class="nounderline abstract_t">Bayly JE, Bernat D, Porter L, Choi K. Secondhand Exposure to Aerosols From Electronic Nicotine Delivery Systems and Asthma Exacerbations Among Youth With Asthma. Chest 2019; 155:88.</a></li><li><a class="nounderline abstract_t">Overbeek DL, Kass AP, Chiel LE, et al. A review of toxic effects of electronic cigarettes/vaping in adolescents and young adults. Crit Rev Toxicol 2020; 50:531.</a></li><li><a class="nounderline abstract_t">Matsui EC, Abramson SL, Sandel MT, et al. Indoor Environmental Control Practices and Asthma Management. Pediatrics 2016; 138.</a></li><li><a class="nounderline abstract_t">De Vera MJ, Drapkin S, Moy JN. Association of recurrent wheezing with sensitivity to cockroach allergen in inner-city children. Ann Allergy Asthma Immunol 2003; 91:455.</a></li><li><a class="nounderline abstract_t">Matsui EC, Wood RA, Rand C, et al. Cockroach allergen exposure and sensitization in suburban middle-class children with asthma. J Allergy Clin Immunol 2003; 112:87.</a></li><li><a class="nounderline abstract_t">Perry T, Matsui E, Merriman B, et al. The prevalence of rat allergen in inner-city homes and its relationship to sensitization and asthma morbidity. J Allergy Clin Immunol 2003; 112:346.</a></li><li><a class="nounderline abstract_t">Gruchalla RS, Pongracic J, Plaut M, et al. Inner City Asthma Study: relationships among sensitivity, allergen exposure, and asthma morbidity. J Allergy Clin Immunol 2005; 115:478.</a></li><li><a class="nounderline abstract_t">Nelson HS, Szefler SJ, Jacobs J, et al. The relationships among environmental allergen sensitization, allergen exposure, pulmonary function, and bronchial hyperresponsiveness in the Childhood Asthma Management Program. J Allergy Clin Immunol 1999; 104:775.</a></li><li><a class="nounderline abstract_t">Erbas B, Akram M, Dharmage SC, et al. The role of seasonal grass pollen on childhood asthma emergency department presentations. Clin Exp Allergy 2012; 42:799.</a></li><li><a class="nounderline abstract_t">Samet JM, Marbury MC, Spengler JD. Health effects and sources of indoor air pollution. Part I. Am Rev Respir Dis 1987; 136:1486.</a></li><li><a class="nounderline abstract_t">Chauhan AJ, Inskip HM, Linaker CH, et al. Personal exposure to nitrogen dioxide (NO2) and the severity of virus-induced asthma in children. Lancet 2003; 361:1939.</a></li><li><a class="nounderline abstract_t">Wright RJ. Epidemiology of stress and asthma: from constricting communities and fragile families to epigenetics. Immunol Allergy Clin North Am 2011; 31:19.</a></li><li><a class="nounderline abstract_t">Eichenfield LF, Hanifin JM, Beck LA, et al. Atopic dermatitis and asthma: parallels in the evolution of treatment. Pediatrics 2003; 111:608.</a></li><li class="breakAll">Branum AM, Lukacs SL. Food allergy amoung US children: Trends in prevalence and hospitalizations. NCHS data brief, no. 10, National Center for Health Statistics; Hyattsville, MD 2008.</li><li><a class="nounderline abstract_t">Roberts G, Patel N, Levi-Schaffer F, et al. Food allergy as a risk factor for life-threatening asthma in childhood: a case-controlled study. J Allergy Clin Immunol 2003; 112:168.</a></li><li><a class="nounderline abstract_t">Denning DW, O'Driscoll BR, Hogaboam CM, et al. The link between fungi and severe asthma: a summary of the evidence. Eur Respir J 2006; 27:615.</a></li><li><a class="nounderline abstract_t">Matsuoka H, Niimi A, Matsumoto H, et al. Specific IgE response to trichophyton and asthma severity. Chest 2009; 135:898.</a></li><li><a class="nounderline abstract_t">Hattevig G, Kjellman B, Björkstén B. Appearance of IgE antibodies to ingested and inhaled allergens during the first 12 years of life in atopic and non-atopic children. Pediatr Allergy Immunol 1993; 4:182.</a></li><li><a class="nounderline abstract_t">Dold S, Wjst M, von Mutius E, et al. Genetic risk for asthma, allergic rhinitis, and atopic dermatitis. Arch Dis Child 1992; 67:1018.</a></li><li><a class="nounderline abstract_t">Kaufman HS, Frick OL. The development of allergy in infants of allergic parents: a prospective study concerning the role of heredity. Ann Allergy 1976; 37:410.</a></li><li><a class="nounderline abstract_t">Bjerg A, Hedman L, Perzanowski MS, et al. Family history of asthma and atopy: in-depth analyses of the impact on asthma and wheeze in 7- to 8-year-old children. Pediatrics 2007; 120:741.</a></li><li><a class="nounderline abstract_t">Happle R, Schnyder UW. Evidence for the Carter effect in atopy. Int Arch Allergy Appl Immunol 1982; 68:90.</a></li><li><a class="nounderline abstract_t">Melén E, Kere J, Pershagen G, et al. Influence of male sex and parental allergic disease on childhood wheezing: role of interactions. Clin Exp Allergy 2004; 34:839.</a></li><li><a class="nounderline abstract_t">Rönmark E, Jönsson E, Platts-Mills T, Lundbäck B. Different pattern of risk factors for atopic and nonatopic asthma among children--report from the Obstructive Lung Disease in Northern Sweden Study. Allergy 1999; 54:926.</a></li><li><a class="nounderline abstract_t">Burke W, Fesinmeyer M, Reed K, et al. Family history as a predictor of asthma risk. Am J Prev Med 2003; 24:160.</a></li><li><a class="nounderline abstract_t">Ross KR, Storfer-Isser A, Hart MA, et al. Sleep-disordered breathing is associated with asthma severity in children. J Pediatr 2012; 160:736.</a></li><li><a class="nounderline abstract_t">Bhattacharjee R, Choi BH, Gozal D, Mokhlesi B. Association of adenotonsillectomy with asthma outcomes in children: a longitudinal database analysis. PLoS Med 2014; 11:e1001753.</a></li><li><a class="nounderline abstract_t">Bender BG, Bartlett SJ, Rand CS, et al. Impact of interview mode on accuracy of child and parent report of adherence with asthma-controller medication. Pediatrics 2007; 120:e471.</a></li><li><a class="nounderline abstract_t">Hanania NA, Wittman R, Kesten S, Chapman KR. Medical personnel's knowledge of and ability to use inhaling devices. Metered-dose inhalers, spacing chambers, and breath-actuated dry powder inhalers. Chest 1994; 105:111.</a></li><li><a class="nounderline abstract_t">De Blaquiere P, Christensen DB, Carter WB, Martin TR. Use and misuse of metered-dose inhalers by patients with chronic lung disease. A controlled, randomized trial of two instruction methods. Am Rev Respir Dis 1989; 140:910.</a></li><li><a class="nounderline abstract_t">Khoshoo V, Le T, Haydel RM Jr, et al. Role of gastroesophageal reflux in older children with persistent asthma. Chest 2003; 123:1008.</a></li><li><a class="nounderline abstract_t">Debley JS, Carter ER, Redding GJ. Prevalence and impact of gastroesophageal reflux in adolescents with asthma: a population-based study. Pediatr Pulmonol 2006; 41:475.</a></li><li><a class="nounderline abstract_t">Zeiger RS, Szefler SJ, Phillips BR, et al. Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma. J Allergy Clin Immunol 2006; 117:45.</a></li><li><a class="nounderline abstract_t">Szefler SJ, Phillips BR, Martinez FD, et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol 2005; 115:233.</a></li><li><a class="nounderline abstract_t">Federico MJ, Covar RA, Brown EE, et al. Racial differences in T-lymphocyte response to glucocorticoids. Chest 2005; 127:571.</a></li><li><a class="nounderline abstract_t">Gauvreau GM, Inman MD, Kelly M, et al. Increased levels of airway neutrophils reduce the inhibitory effects of inhaled glucocorticosteroids on allergen-induced airway eosinophils. Can Respir J 2002; 9:26.</a></li><li class="breakAll">National Asthma Education and Prevention Program: Expert panel report 3 (EPR3): Guidelines for the diagnosis and management of asthma. Bethesda, MD: National Heart, Lung, and Blood Institute, 2007. (NIH publication no. 08-4051). www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm (Accessed on February 11, 2010).</li><li><a class="nounderline abstract_t">Taylor WR, Newacheck PW. Impact of childhood asthma on health. Pediatrics 1992; 90:657.</a></li><li><a class="nounderline abstract_t">Weiss KB, Gergen PJ, Hodgson TA. An economic evaluation of asthma in the United States. N Engl J Med 1992; 326:862.</a></li><li><a class="nounderline abstract_t">Wang LY, Zhong Y, Wheeler L. Direct and indirect costs of asthma in school-age children. Prev Chronic Dis 2005; 2:A11.</a></li><li><a class="nounderline abstract_t">Vahlkvist S, Pedersen S. Fitness, daily activity and body composition in children with newly diagnosed, untreated asthma. Allergy 2009; 64:1649.</a></li><li><a class="nounderline abstract_t">Weiler JM, Layton T, Hunt M. Asthma in United States Olympic athletes who participated in the 1996 Summer Games. J Allergy Clin Immunol 1998; 102:722.</a></li><li><a class="nounderline abstract_t">Chen E, Chim LS, Strunk RC, Miller GE. The role of the social environment in children and adolescents with asthma. Am J Respir Crit Care Med 2007; 176:644.</a></li><li><a class="nounderline abstract_t">Michelson PH, Williams LW, Benjamin DK, Barnato AE. Obesity, inflammation, and asthma severity in childhood: data from the National Health and Nutrition Examination Survey 2001-2004. Ann Allergy Asthma Immunol 2009; 103:381.</a></li><li><a class="nounderline abstract_t">Musaad SM, Patterson T, Ericksen M, et al. Comparison of anthropometric measures of obesity in childhood allergic asthma: central obesity is most relevant. J Allergy Clin Immunol 2009; 123:1321.</a></li><li><a class="nounderline abstract_t">Ginde AA, Santillan AA, Clark S, Camargo CA Jr. Body mass index and acute asthma severity among children presenting to the emergency department. Pediatr Allergy Immunol 2010; 21:480.</a></li><li><a class="nounderline abstract_t">Hom J, Morley EJ, Sasso P, Sinert R. Body mass index and pediatric asthma outcomes. Pediatr Emerg Care 2009; 25:569.</a></li><li><a class="nounderline abstract_t">Black MH, Zhou H, Takayanagi M, et al. Increased asthma risk and asthma-related health care complications associated with childhood obesity. Am J Epidemiol 2013; 178:1120.</a></li><li><a class="nounderline abstract_t">British Thoracic Society Scottish Intercollegiate Guidelines Network. British Guideline on the Management of Asthma. Thorax 2008; 63 Suppl 4:iv1.</a></li><li><a class="nounderline abstract_t">Papadopoulos NG, Arakawa H, Carlsen KH, et al. International consensus on (ICON) pediatric asthma. Allergy 2012; 67:976.</a></li><li><a class="nounderline abstract_t">Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society. Am Rev Respir Dis 1991; 144:1202.</a></li><li><a class="nounderline abstract_t">Paull K, Covar R, Jain N, et al. Do NHLBI lung function criteria apply to children? A cross-sectional evaluation of childhood asthma at National Jewish Medical and Research Center, 1999-2002. Pediatr Pulmonol 2005; 39:311.</a></li><li><a class="nounderline abstract_t">Bacharier LB, Dawson C, Bloomberg GR, et al. Hospitalization for asthma: atopic, pulmonary function, and psychological correlates among participants in the Childhood Asthma Management Program. Pediatrics 2003; 112:e85.</a></li><li><a class="nounderline abstract_t">Fuhlbrigge AL, Kitch BT, Paltiel AD, et al. FEV(1) is associated with risk of asthma attacks in a pediatric population. J Allergy Clin Immunol 2001; 107:61.</a></li><li><a class="nounderline abstract_t">Fuhlbrigge AL, Weiss ST, Kuntz KM, et al. Forced expiratory volume in 1 second percentage improves the classification of severity among children with asthma. Pediatrics 2006; 118:e347.</a></li><li><a class="nounderline abstract_t">Simon MR, Chinchilli VM, Phillips BR, et al. Forced expiratory flow between 25% and 75% of vital capacity and FEV1/forced vital capacity ratio in relation to clinical and physiological parameters in asthmatic children with normal FEV1 values. J Allergy Clin Immunol 2010; 126:527.</a></li><li><a class="nounderline abstract_t">Galant SP, Morphew T, Amaro S, Liao O. Value of the bronchodilator response in assessing controller naïve asthmatic children. J Pediatr 2007; 151:457.</a></li><li><a class="nounderline abstract_t">Dundas I, Chan EY, Bridge PD, McKenzie SA. Diagnostic accuracy of bronchodilator responsiveness in wheezy children. Thorax 2005; 60:13.</a></li><li><a class="nounderline abstract_t">Tse SM, Gold DR, Sordillo JE, et al. Diagnostic accuracy of the bronchodilator response in children. J Allergy Clin Immunol 2013; 132:554.</a></li><li><a class="nounderline abstract_t">Jenkins HA, Cherniack R, Szefler SJ, et al. A comparison of the clinical characteristics of children and adults with severe asthma. Chest 2003; 124:1318.</a></li><li><a class="nounderline abstract_t">Bacharier LB, Strunk RC, Mauger D, et al. Classifying asthma severity in children: mismatch between symptoms, medication use, and lung function. Am J Respir Crit Care Med 2004; 170:426.</a></li><li><a class="nounderline abstract_t">Spahn JD, Cherniack R, Paull K, Gelfand EW. Is forced expiratory volume in one second the best measure of severity in childhood asthma? Am J Respir Crit Care Med 2004; 169:784.</a></li><li><a class="nounderline abstract_t">Childhood Asthma Management Program Research Group, Szefler S, Weiss S, et al. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000; 343:1054.</a></li><li><a class="nounderline abstract_t">Sorkness RL, Zoratti EM, Kattan M, et al. Obstruction phenotype as a predictor of asthma severity and instability in children. J Allergy Clin Immunol 2018; 142:1090.</a></li><li><a class="nounderline abstract_t">Song TW, Kim KW, Kim ES, et al. Utility of impulse oscillometry in young children with asthma. Pediatr Allergy Immunol 2008; 19:763.</a></li><li><a class="nounderline abstract_t">Bickel S, Popler J, Lesnick B, Eid N. Impulse oscillometry: interpretation and practical applications. Chest 2014; 146:841.</a></li><li><a class="nounderline abstract_t">Beydon N, Davis SD, Lombardi E, et al. An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children. Am J Respir Crit Care Med 2007; 175:1304.</a></li><li class="breakAll">BTS/SIGN Asthma Guidelines: 2012. http://www.brit-thoracic.org.uk/guidelines/asthma-guidelines.aspx.</li><li><a class="nounderline abstract_t">Ducharme FM, Davis GM. Measurement of respiratory resistance in the emergency department: feasibility in young children with acute asthma. Chest 1997; 111:1519.</a></li><li><a class="nounderline abstract_t">Ducharme FM, Davis GM, Ducharme GR. Pediatric reference values for respiratory resistance measured by forced oscillation. Chest 1998; 113:1322.</a></li><li><a class="nounderline abstract_t">Sol IS, Kim YH, Kim S, et al. Assessment of within-breath impulse oscillometry parameters in children with asthma. Pediatr Pulmonol 2019; 54:117.</a></li><li><a class="nounderline abstract_t">Larsen GL, Morgan W, Heldt GP, et al. Impulse oscillometry versus spirometry in a long-term study of controller therapy for pediatric asthma. J Allergy Clin Immunol 2009; 123:861.</a></li><li><a class="nounderline abstract_t">Shi Y, Aledia AS, Tatavoosian AV, et al. Relating small airways to asthma control by using impulse oscillometry in children. J Allergy Clin Immunol 2012; 129:671.</a></li><li><a class="nounderline abstract_t">Komarow HD, Skinner J, Young M, et al. A study of the use of impulse oscillometry in the evaluation of children with asthma: analysis of lung parameters, order effect, and utility compared with spirometry. Pediatr Pulmonol 2012; 47:18.</a></li><li><a class="nounderline abstract_t">Martinez FD, Wright AL, Taussig LM, et al. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995; 332:133.</a></li><li><a class="nounderline abstract_t">Lewiston NJ. What is wheezy bronchitis? Pediatr Ann 1989; 18:792.</a></li><li class="breakAll">2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group https://www.nhlbi.nih.gov/health-topics/all-publications-and-resources/2020-focused-updates-asthma-management-guidelines (Accessed on January 25, 2021).</li><li><a class="nounderline abstract_t">Jones A, Bowen M. Screening for childhood asthma using an exercise test. Br J Gen Pract 1994; 44:127.</a></li><li><a class="nounderline abstract_t">Kattan M, Keens TG, Mellis CM, Levison H. The response to exercise in normal and asthmatic children. J Pediatr 1978; 92:718.</a></li><li><a class="nounderline abstract_t">McFadden ER Jr. Exercise-induced asthma. Assessment of current etiologic concepts. Chest 1987; 91:151S.</a></li><li><a class="nounderline abstract_t">Crapo RO, Casaburi R, Coates AL, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000; 161:309.</a></li></ol></div><div id="topicVersionRevision">Topic 5742 Version 41.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15080825" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : The global burden of asthma: executive summary of the GINA Dissemination Committee report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15080825" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : The global burden of asthma: executive summary of the GINA Dissemination Committee report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15080825" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : The global burden of asthma: executive summary of the GINA Dissemination Committee report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19237391" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19912154" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Is the prevalence of asthma declining? Systematic review of epidemiological studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32020334" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Asthma epidemiology and risk factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32020334" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Asthma epidemiology and risk factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25875829" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Updated prevalences of asthma, allergy, and airway symptoms, and a systematic review of trends over time for childhood asthma in Shanghai, China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26712860" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Changing Trends in Asthma Prevalence Among Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29420459" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Vital Signs: Asthma in Children - United States, 2001-2016.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17822448" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Impact of gender on asthma in childhood and adolescence: a GA2LEN review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21382080" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Sex-specific trends in prevalence of childhood asthma over 30 years in Patras, Greece.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20874825" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Prevalence of asthma and bronchial hyperreactivity in Danish schoolchildren: no change over 10 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20408968" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Asthma in late adolescence--farm childhood is protective and the prevalence increase has levelled off.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15994260" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : No increase in the prevalence of asthma, allergies, and atopic sensitisation among children in Germany: 1992-2001.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17133524" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Changing trends in sex specific prevalence rates for childhood asthma, eczema, and hay fever.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16685002" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Evaluation and outcome of young children with chronic cough.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1672866" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Cough variant asthma: a review of the clinical literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2368957" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Sudden asphyxic asthma: a distinct entity?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2606186" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Fatal asthma in a young patient with severe bronchial hyperresponsiveness but stable peak flow records.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15342851" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Duration of mechanical ventilation in life-threatening pediatric asthma: description of an acute asphyxial subgroup.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15301803" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : [From asthma attack to fatal asthma in children].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11153581" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : A nationwide survey in Germany on fatal asthma and near-fatal asthma in children: different entities?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18820588" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Viral respiratory infection and the link to asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15316497" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10700670" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : A case-control study of the role of cold symptoms and other historical triggering factors in asthma exacerbations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16522453" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : The September epidemic of asthma hospitalization: school children as disease vectors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10911633" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Sinusitis and pediatric asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12628875" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Concomitant chronic sinusitis treatment in children with mild asthma: the effect on bronchial hyperresponsiveness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15156467" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Mycoplasma pneumoniae and asthma in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8019629" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : The association of Chlamydia pneumoniae infection and reactive airway disease in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15735056" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : The bronchial lavage of pediatric patients with asthma contains infectious Chlamydia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8643325" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Exercise-induced bronchospasm in children: effects and therapies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20668015" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Indirect challenge tests: Airway hyperresponsiveness in asthma: its measurement and clinical significance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10469821" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Keeping children with exercise-induced asthma active.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8209052" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Exercised-induced asthma revisited.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9920215" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Prevalence and characteristics of exercise-induced asthma in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23633375" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Swimming training for asthma in children and adolescents aged 18 years and under.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19061232" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Swimming pool, respiratory health, and childhood asthma: should we change our beliefs?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20889905" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Swimming pool attendance, asthma, allergies, and lung function in the Avon Longitudinal Study of Parents and Children cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21471055" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Pro: swimming in chlorinated pools and risk of asthma: we can now carry on sending our children to swimming pools!</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21471056" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Con: respiratory risks associated with chlorinated swimming pools: a complex pattern of exposure and effects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9516904" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Health effects of passive smoking. 3. Parental smoking and prevalence of respiratory symptoms and asthma in school age children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11177060" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Health effects related to environmental tobacco smoke exposure in children in the United States: data from the Third National Health and Nutrition Examination Survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2011160" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : The influence of a family history of asthma and parental smoking on airway responsiveness in early infancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32239706" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Acute effects of e-cigarette vaping on pulmonary function and airway inflammation in healthy individuals and in patients with asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30359612" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Secondhand Exposure to Aerosols From Electronic Nicotine Delivery Systems and Asthma Exacerbations Among Youth With Asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32715837" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : A review of toxic effects of electronic cigarettes/vaping in adolescents and young adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27940791" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Indoor Environmental Control Practices and Asthma Management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14692428" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Association of recurrent wheezing with sensitivity to cockroach allergen in inner-city children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12847484" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Cockroach allergen exposure and sensitization in suburban middle-class children with asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12897741" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : The prevalence of rat allergen in inner-city homes and its relationship to sensitization and asthma morbidity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15753892" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Inner City Asthma Study: relationships among sensitivity, allergen exposure, and asthma morbidity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10518821" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : The relationships among environmental allergen sensitization, allergen exposure, pulmonary function, and bronchial hyperresponsiveness in the Childhood Asthma Management Program.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22515396" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : The role of seasonal grass pollen on childhood asthma emergency department presentations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3318602" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Health effects and sources of indoor air pollution. Part I.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12801737" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Personal exposure to nitrogen dioxide (NO2) and the severity of virus-induced asthma in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21094921" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Epidemiology of stress and asthma: from constricting communities and fragile families to epigenetics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12612244" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Atopic dermatitis and asthma: parallels in the evolution of treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12612244" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Atopic dermatitis and asthma: parallels in the evolution of treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12847494" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Food allergy as a risk factor for life-threatening asthma in childhood: a case-controlled study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16507864" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : The link between fungi and severe asthma: a summary of the evidence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19188557" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Specific IgE response to trichophyton and asthma severity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8298709" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Appearance of IgE antibodies to ingested and inhaled allergens during the first 12 years of life in atopic and non-atopic children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1520004" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Genetic risk for asthma, allergic rhinitis, and atopic dermatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/999060" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : The development of allergy in infants of allergic parents: a prospective study concerning the role of heredity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17908760" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Family history of asthma and atopy: in-depth analyses of the impact on asthma and wheeze in 7- to 8-year-old children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7076324" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Evidence for the Carter effect in atopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15196268" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Influence of male sex and parental allergic disease on childhood wheezing: role of interactions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10505455" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Different pattern of risk factors for atopic and nonatopic asthma among children--report from the Obstructive Lung Disease in Northern Sweden Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12568822" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Family history as a predictor of asthma risk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22133422" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Sleep-disordered breathing is associated with asthma severity in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25369282" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Association of adenotonsillectomy with asthma outcomes in children: a longitudinal database analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17698578" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Impact of interview mode on accuracy of child and parent report of adherence with asthma-controller medication.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8275720" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Medical personnel's knowledge of and ability to use inhaling devices. Metered-dose inhalers, spacing chambers, and breath-actuated dry powder inhalers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2679269" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Use and misuse of metered-dose inhalers by patients with chronic lung disease. A controlled, randomized trial of two instruction methods.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12684287" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Role of gastroesophageal reflux in older children with persistent asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16547933" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Prevalence and impact of gastroesophageal reflux in adolescents with asthma: a population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16387583" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15696076" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15705998" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Racial differences in T-lymphocyte response to glucocorticoids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11856987" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Increased levels of airway neutrophils reduce the inhibitory effects of inhaled glucocorticosteroids on allergen-induced airway eosinophils.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11856987" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Increased levels of airway neutrophils reduce the inhibitory effects of inhaled glucocorticosteroids on allergen-induced airway eosinophils.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1408534" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Impact of childhood asthma on health.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1542323" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : An economic evaluation of asthma in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15670464" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Direct and indirect costs of asthma in school-age children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19489758" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Fitness, daily activity and body composition in children with newly diagnosed, untreated asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9819287" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Asthma in United States Olympic athletes who participated in the 1996 Summer Games.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17556714" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : The role of the social environment in children and adolescents with asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19927535" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Obesity, inflammation, and asthma severity in childhood: data from the National Health and Nutrition Examination Survey 2001-2004.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19439348" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Comparison of anthropometric measures of obesity in childhood allergic asthma: central obesity is most relevant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19548965" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Body mass index and acute asthma severity among children presenting to the emergency department.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19755889" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Body mass index and pediatric asthma outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23924576" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Increased asthma risk and asthma-related health care complications associated with childhood obesity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18463203" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : British Guideline on the Management of Asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22702533" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : International consensus on (ICON) pediatric asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1952453" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15678505" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Do NHLBI lung function criteria apply to children? A cross-sectional evaluation of childhood asthma at National Jewish Medical and Research Center, 1999-2002.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12897312" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Hospitalization for asthma: atopic, pulmonary function, and psychological correlates among participants in the Childhood Asthma Management Program.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11149992" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : FEV(1) is associated with risk of asthma attacks in a pediatric population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16864642" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Forced expiratory volume in 1 second percentage improves the classification of severity among children with asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20638110" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Forced expiratory flow between 25% and 75% of vital capacity and FEV1/forced vital capacity ratio in relation to clinical and physiological parameters in asthmatic children with normal FEV1 values.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17961685" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Value of the bronchodilator response in assessing controller naïve asthmatic children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15618576" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Diagnostic accuracy of bronchodilator responsiveness in wheezy children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23683464" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Diagnostic accuracy of the bronchodilator response in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14555561" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : A comparison of the clinical characteristics of children and adults with severe asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15172893" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Classifying asthma severity in children: mismatch between symptoms, medication use, and lung function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14754761" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Is forced expiratory volume in one second the best measure of severity in childhood asthma?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11027739" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Long-term effects of budesonide or nedocromil in children with asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29146272" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Obstruction phenotype as a predictor of asthma severity and instability in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18331417" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Utility of impulse oscillometry in young children with asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25180727" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Impulse oscillometry: interpretation and practical applications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17545458" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17545458" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9187167" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Measurement of respiratory resistance in the emergency department: feasibility in young children with acute asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9596314" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Pediatric reference values for respiratory resistance measured by forced oscillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30536749" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Assessment of within-breath impulse oscillometry parameters in children with asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19070356" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Impulse oscillometry versus spirometry in a long-term study of controller therapy for pediatric asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22178635" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Relating small airways to asthma control by using impulse oscillometry in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22170806" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : A study of the use of impulse oscillometry in the evaluation of children with asthma: analysis of lung parameters, order effect, and utility compared with spirometry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7800004" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Asthma and wheezing in the first six years of life. The Group Health Medical Associates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2687783" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : What is wheezy bronchitis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2687783" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : What is wheezy bronchitis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8204321" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Screening for childhood asthma using an exercise test.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/641618" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : The response to exercise in normal and asthmatic children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3556064" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Exercise-induced asthma. Assessment of current etiologic concepts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10619836" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
